AR and breast carcinoma: Prior studies have shown that AR may have utility as a predictive or prognostic marker, or may even be a viable therapeutic target for certain breast cancer subtypes.13,14 In a nested case–control study within the NHS and NHSII cohorts, we found no association between AR expression in normal TDLUs and the subsequent incidence of breast cancer.